Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cardiovascular Drugs and Therapy
Metadata
Title
Mitochondrial-nuclear Cross-talk in the Aging and Failing Heart
Authors
José Marín-García
YeQing Pi
Michael J. Goldenthal
Publication date
01-12-2006
Publisher
Kluwer Academic Publishers
Published in
Cardiovascular Drugs and Therapy / Issue 6/2006
Print ISSN: 0920-3206
Electronic ISSN: 1573-7241
DOI
https://doi.org/10.1007/s10557-006-0584-6

Other articles of this Issue 6/2006

Cardiovascular Drugs and Therapy 6/2006 Go to the issue

Review

Malonyl-CoA Decarboxylase Inhibition as a Novel Approach to Treat Ischemic Heart Disease

Review

The Interplay between Pro-Death and Pro-Survival Signaling Pathways in Myocardial Ischemia/Reperfusion Injury: Apoptosis Meets Autophagy

Abstracts

Abstracts and Review Articles from the Society for Heart and Vascular Metabolism Meeting entitled “CARDIAC ENERGY METABOLISM IN HEART FAILURE: FROM CONCEPTS TO THERAPIES” held in Semiahmoo, Washington, USA, September 6–9 2006

Review

Cardiac Metabolism and Mechanics are Altered by Genetic Loss of Lipoprotein Triglyceride Lipolysis

Review

Regulation of Sarcolemmal Transport of Substrates in the Healthy and Diseased Heart

Review

Mitochondrial Permeability Transition in Cardiac Cell Injury and Death

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits